+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceutical Therapy Market - Global Forecast 2026-2032- Product Image
Radiopharmaceutical Therapy Market - Global Forecast 2026-2032- Product Image
Sale

Radiopharmaceutical Therapy Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127153
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radiopharmaceutical Therapy Market is projected to reach USD 9.97 Billion in 2026. It is expected to continue growing at a CAGR of 10.55%, reaching USD 18.52 Billion by 2032.

Radiopharmaceutical Therapy: Executive Overview

Radiopharmaceutical therapy uses radioactive compounds to deliver targeted radiation to diseased tissue, particularly in oncology. Its development is supported by advances in molecular targeting, diagnostic imaging, nuclear medicine infrastructure, and clinical evidence. Adoption depends on appropriate patient selection, isotope availability, treatment-center capacity, radiation-safety systems, reimbursement, and coordination across specialist care pathways.

Clinical Integration Is Reshaping Radiopharmaceutical Therapy

The field is shifting from isolated procedures toward integrated theranostic pathways that connect biomarker identification, molecular imaging, treatment selection, dosimetry, administration, and follow-up. More precise patient stratification is encouraging treatment personalization, while improvements in hospital workflows and multidisciplinary coordination are helping address the operational complexity of radioactive products. Persistent constraints include specialized workforce requirements, supply-chain reliability, regulatory compliance, waste management, and equitable access outside major medical centers.

Artificial Intelligence Strengthens Selection, Planning, and Follow-Up

Artificial intelligence can support radiopharmaceutical therapy by improving image interpretation, identifying eligible patients, segmenting lesions, estimating absorbed dose, and monitoring treatment response. It may also assist scheduling, isotope logistics, quality control, and clinical documentation. Benefits depend on representative training data, external validation, transparent performance measures, cybersecurity, and human oversight. AI should complement-not replace-nuclear medicine, oncology, medical physics, pharmacy, and radiation-safety expertise.

Regional Insights: Infrastructure and Access Define Adoption

North America benefits from advanced nuclear medicine capabilities, specialized treatment centers, and established research networks, while access still varies by geography and payer policy. Europe combines strong clinical and regulatory expertise with cross-border differences in reimbursement, isotope logistics, and healthcare capacity. Asia-Pacific is expanding clinical and manufacturing capabilities, with considerable variation between mature systems and emerging markets. Latin America is developing specialized services but faces uneven infrastructure, workforce availability, and supply continuity. The Middle East is investing in advanced healthcare capacity, although access is concentrated in leading institutions. Africa faces the greatest disparities in isotope supply, equipment, specialist training, and referral pathways, making regional collaboration and capacity building especially important.

Group Insights: Cooperation Can Reduce Capability Gaps

ASEAN members can benefit from shared training, coordinated procurement, and referral networks that address differing levels of nuclear medicine maturity. BRICS cooperation can support isotope production, technical exchange, clinical research, and workforce development while accounting for varied regulatory systems. The European Union can strengthen cross-border standards, supply resilience, and patient referral coordination. G7 systems are positioned to advance evidence generation, quality standards, and responsible innovation. GCC countries can use centralized specialist infrastructure and coordinated health strategies to expand access, while NATO members may benefit from shared preparedness, logistics, and technical standards where relevant to critical healthcare supply chains.

Country Insights: Capability Is Uneven Across Major Markets

The United States and Canada have sophisticated clinical and research ecosystems, but regional access, reimbursement, and isotope logistics remain important considerations. The United Kingdom, France, Germany, Italy, and Spain possess established nuclear medicine capabilities, with implementation shaped by national regulation, hospital organization, and coverage decisions. Japan and South Korea combine advanced healthcare infrastructure with strong technical expertise, while China is expanding clinical capacity and domestic capabilities. India is developing specialized services amid substantial urban-rural variation. Australia has strong tertiary-care expertise but faces geographic distance and supply challenges. Brazil and Mexico are building access through specialized institutions, while Russia’s capabilities are influenced by domestic production, regulation, and healthcare-system coordination.

Priorities for Leaders: Build Reliable, Evidence-Based Care Pathways

Industry leaders should align therapy development with validated biomarkers, clinically meaningful outcomes, and practical treatment workflows. They should diversify isotope sourcing, strengthen quality systems, and establish contingency plans for transport and production interruptions. Investment in dosimetry, radiation safety, workforce training, and regional referral networks can improve operational readiness. Partnerships with healthcare providers should address reimbursement evidence, patient education, and follow-up capacity. AI deployments should use governed data, prospective validation, auditability, and clinician oversight. Access strategies should also account for rural populations, smaller hospitals, and countries with limited nuclear medicine infrastructure.

Research Methodology: Structured Synthesis of Market-Relevant Evidence

This executive summary applies a structured qualitative review of radiopharmaceutical therapy across clinical practice, technology, regulation, infrastructure, supply chains, workforce, and access. Insights are organized by the specified regions, country groups, and countries, with emphasis on observable system characteristics rather than unsupported quantitative claims. The analysis avoids market estimates, market shares, forecasts, and company-specific claims. Conclusions should be supplemented with current peer-reviewed studies, regulatory documents, clinical guidelines, reimbursement policies, isotope-production data, and local health-system assessments before investment or implementation decisions.

Conclusion: Sustainable Growth Requires Precision and System Readiness

Radiopharmaceutical therapy is advancing through more targeted clinical approaches, stronger theranostic integration, and expanding use of digital tools. Its long-term impact will depend not only on therapeutic innovation but also on dependable isotope supply, trained personnel, compliant facilities, validated evidence, and equitable referral pathways. Leaders that connect clinical precision with operational resilience and responsible AI governance will be better positioned to improve patient access and outcomes across diverse healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Radiopharmaceutical Therapy Market, by Therapy Type
7.1. Introduction
7.2. Alpha Emitter Therapy
7.2.1. Actinium-225
7.2.2. Radium-223
7.3. Beta Emitter Therapy
7.3.1. Iodine-131
7.3.2. Lutetium-177
7.3.3. Yttrium-90
8. Radiopharmaceutical Therapy Market, by Radioisotope
8.1. Introduction
8.2. Actinium-225
8.3. Iodine-131
8.4. Lutetium-177
8.5. Radium-223
8.6. Yttrium-90
9. Radiopharmaceutical Therapy Market, by Indication
9.1. Introduction
9.2. Bone Metastases
9.3. Neuroendocrine Tumors
9.4. Prostate Cancer
9.5. Thyroid Cancer
10. Radiopharmaceutical Therapy Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Research Institutes
10.4. Specialty Clinics
11. Radiopharmaceutical Therapy Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Radiopharmaceutical Therapy Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Radiopharmaceutical Therapy Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Radiopharmaceutical Therapy Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Actinium Pharmaceuticals, Inc.
16.2. AdvanCell Isotopes Pty Ltd.
16.3. Aktis Oncology Inc.
16.4. Alpha Tau Medical Ltd.
16.5. Ariceum Therapeutics GmbH
16.6. ARTBIO Inc.
16.7. Bayer AG
16.8. Blue Earth Therapeutics Ltd.
16.9. BWXT Medical Ltd.
16.10. Cellectar Biosciences, Inc.
16.11. Clarity Pharmaceuticals Ltd.
16.12. Convergent Therapeutics, Inc.
16.13. Eckert & Ziegler AG
16.14. Eli Lilly and Company
16.15. Full-Life Technologies Ltd.
16.16. Fusion Pharmaceuticals Inc.
16.17. GE HealthCare Technologies Inc.
16.18. Jubilant Pharmova Limited
16.19. Lantheus Holdings, Inc.
16.20. Novartis AG
16.21. Oncoinvent ASA
16.22. Perspective Therapeutics Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Radiopharmaceutical Therapy Market, Years Considered for the Study
FIGURE 2. Global Radiopharmaceutical Therapy Market, Research Design
FIGURE 3. Global Radiopharmaceutical Therapy Market, Research Framework
FIGURE 4. Global Radiopharmaceutical Therapy Market, Data Triangulation
FIGURE 5. Global Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Radiopharmaceutical Therapy Market Size, by Therapy Type, 2025 vs 2032 (%)
FIGURE 7. Global Radiopharmaceutical Therapy Market Size, by Therapy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Radiopharmaceutical Therapy Market Size, by Radioisotope, 2025 vs 2032 (%)
FIGURE 9. Global Radiopharmaceutical Therapy Market Size, by Radioisotope, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Radiopharmaceutical Therapy Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 11. Global Radiopharmaceutical Therapy Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Radiopharmaceutical Therapy Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Radiopharmaceutical Therapy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Radiopharmaceutical Therapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Radiopharmaceutical Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Radiopharmaceutical Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Radiopharmaceutical Therapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Radiopharmaceutical Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Radiopharmaceutical Therapy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Radiopharmaceutical Therapy Market Segmentation & Coverage
TABLE 2. Global Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 4. Global Alpha Emitter Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Alpha Emitter Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Alpha Emitter Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Actinium-225 Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Radium-223 Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Radium-223 Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Radium-223 Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Beta Emitter Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Beta Emitter Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Beta Emitter Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Iodine-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Iodine-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Iodine-131 Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Yttrium-90 Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Yttrium-90 Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Yttrium-90 Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 26. Global Actinium-225 Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Actinium-225 Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Actinium-225 Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Iodine-131 Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Iodine-131 Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Iodine-131 Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lutetium-177 Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lutetium-177 Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lutetium-177 Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Radium-223 Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Radium-223 Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Radium-223 Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Yttrium-90 Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Yttrium-90 Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Yttrium-90 Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 42. Global Bone Metastases Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Bone Metastases Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Bone Metastases Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Neuroendocrine Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Neuroendocrine Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Neuroendocrine Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Thyroid Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Thyroid Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Thyroid Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. North America Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. North America Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 82. North America Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 83. North America Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 84. North America Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 85. North America Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 86. North America Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. North America Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. Latin America Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Latin America Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 90. Latin America Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 91. Latin America Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 92. Latin America Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 93. Latin America Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. Latin America Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Latin America Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Europe Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Europe Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 98. Europe Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 99. Europe Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 100. Europe Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 101. Europe Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 102. Europe Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Europe Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Middle East Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Middle East Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 106. Middle East Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 107. Middle East Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 108. Middle East Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 109. Middle East Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 110. Middle East Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Middle East Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. Africa Radiopharmaceutical Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Africa Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 114. Africa Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 115. Africa Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 116. Africa Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 117. Africa Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 118. Africa Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Africa Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. Global Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. ASEAN Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. ASEAN Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 123. ASEAN Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 124. ASEAN Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 125. ASEAN Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 126. ASEAN Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 127. ASEAN Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. ASEAN Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. GCC Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. GCC Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 131. GCC Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 132. GCC Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 133. GCC Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 134. GCC Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 135. GCC Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. GCC Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. European Union Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. European Union Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 139. European Union Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 140. European Union Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 141. European Union Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 142. European Union Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 143. European Union Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. European Union Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. BRICS Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. BRICS Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 147. BRICS Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 148. BRICS Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 149. BRICS Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 150. BRICS Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 151. BRICS Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. BRICS Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. G7 Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. G7 Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 155. G7 Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 156. G7 Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 157. G7 Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 158. G7 Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. G7 Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. G7 Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. NATO Radiopharmaceutical Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. NATO Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 163. NATO Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 164. NATO Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 165. NATO Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 166. NATO Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 167. NATO Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. NATO Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Global Radiopharmaceutical Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. United States Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 171. United States Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 172. United States Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 173. United States Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 174. United States Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 175. United States Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. United States Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. United States Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. Canada Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 179. Canada Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 180. Canada Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 181. Canada Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 182. Canada Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 183. Canada Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 184. Canada Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Canada Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. Mexico Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 187. Mexico Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 188. Mexico Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 189. Mexico Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 190. Mexico Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 191. Mexico Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 192. Mexico Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Mexico Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. Brazil Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 195. Brazil Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 196. Brazil Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 197. Brazil Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 198. Brazil Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 199. Brazil Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 200. Brazil Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Brazil Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. United Kingdom Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 203. United Kingdom Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 204. United Kingdom Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 205. United Kingdom Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 206. United Kingdom Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 207. United Kingdom Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. United Kingdom Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. United Kingdom Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 210. Germany Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 211. Germany Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 212. Germany Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 213. Germany Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 214. Germany Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 215. Germany Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 216. Germany Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Germany Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. France Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 219. France Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 220. France Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 221. France Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 222. France Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 223. France Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 224. France Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. France Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Russia Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 227. Russia Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 228. Russia Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 229. Russia Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 230. Russia Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 231. Russia Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 232. Russia Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. Russia Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Italy Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 235. Italy Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 236. Italy Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 237. Italy Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 238. Italy Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 239. Italy Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 240. Italy Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Italy Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Spain Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 243. Spain Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 244. Spain Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 245. Spain Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 246. Spain Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 247. Spain Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 248. Spain Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Spain Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. China Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 251. China Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 252. China Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 253. China Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 254. China Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 255. China Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 256. China Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. China Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 258. India Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 259. India Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 260. India Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 261. India Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 262. India Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 263. India Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 264. India Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. India Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. Japan Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 267. Japan Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 268. Japan Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 269. Japan Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 270. Japan Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 271. Japan Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 272. Japan Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Japan Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 274. Australia Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 275. Australia Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 276. Australia Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 277. Australia Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 278. Australia Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 279. Australia Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 280. Australia Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Australia Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. South Korea Radiopharmaceutical Therapy Market Size, 2017-2032 (USD Million)
TABLE 283. South Korea Radiopharmaceutical Therapy Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 284. South Korea Radiopharmaceutical Therapy Market Size, by Alpha Emitter Therapy, 2017-2032 (USD Million)
TABLE 285. South Korea Radiopharmaceutical Therapy Market Size, by Beta Emitter Therapy, 2017-2032 (USD Million)
TABLE 286. South Korea Radiopharmaceutical Therapy Market Size, by Radioisotope, 2017-2032 (USD Million)
TABLE 287. South Korea Radiopharmaceutical Therapy Market Size, by Indication, 2017-2032 (USD Million)
TABLE 288. South Korea Radiopharmaceutical Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. South Korea Radiopharmaceutical Therapy Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 290. Global Radiopharmaceutical Therapy Market Share, by Key Player, 2025
TABLE 291. Global Radiopharmaceutical Therapy Market, Key Experts

Companies Mentioned

  • Actinium Pharmaceuticals, Inc.
  • AdvanCell Isotopes Pty Ltd.
  • Aktis Oncology Inc.
  • Alpha Tau Medical Ltd.
  • Ariceum Therapeutics GmbH
  • ARTBIO Inc.
  • Bayer AG
  • Blue Earth Therapeutics Ltd.
  • BWXT Medical Ltd.
  • Cellectar Biosciences, Inc.
  • Clarity Pharmaceuticals Ltd.
  • Convergent Therapeutics, Inc.
  • Eckert & Ziegler AG
  • Eli Lilly and Company
  • Full-Life Technologies Ltd.
  • Fusion Pharmaceuticals Inc.
  • GE HealthCare Technologies Inc.
  • Jubilant Pharmova Limited
  • Lantheus Holdings, Inc.
  • Novartis AG
  • Oncoinvent ASA
  • Perspective Therapeutics Inc.

Related Topics

Related Reports

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Radiopharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Radiopharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Radiopharmaceutical Theranostics Market Report 2026 - Product Image

Radiopharmaceutical Theranostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Nuclear Medicine (Radiopharmaceuticals) - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Radiopharmaceutical CDMO - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.